NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM7746590 Query DataSets for GSM7746590
Status Public on Sep 01, 2023
Title pdac_15_before
Sample type RNA
 
Source name pancreatic ductal adenocarcinoma, blood
Organism Homo sapiens
Characteristics tissue: blood
patient diagnosis: Pancreatic Ductal Adenocarcinoma
age: 69
gender: Female
smoking status: Former
alcohol status: Current
baseline ca19-9 (u/ml): 2000
baseline cea (µg/l): 7.2
baseline sii: 201
baseline nlr: 1.2
baseline bilirubin (micromol/l): 6
baseline crp (mg/l): 4.9
disease stage: Metastatic disease
total cycles of folfirinox: 4
progression after 4 cycles (recist 1.1): Progressive disease
overall survival: 5
Extracted molecule total RNA
Extraction protocol The whole-blood samples intended for targeted gene expression analysis were collected in Tempus tubes (Applied Biosystems, Foster City, CA, USA) and subsequently stored at −80 °C. Tempus tubes are designed to contain an RNA-stabilizing reagent, which effectively preserves RNA quality, enabling the measurement of gene expression profiles without the need to isolate peripheral blood mononuclear cells. To extract total RNA from the blood in Tempus tubes, a Tempus Spin RNA Isolation Kit from Thermo Fisher Scientific (Waltham, MA, USA) was employed, following the manufac-turer’s instructions. Subsequently, RNA quality was assessed using an Agilent 2100 Bi-oAnalyzer (Santa Clara, CA, USA). Samples with RNA concentrations below 35 mg/mL were excluded from further analysis. Corrected RNA concentrations were calculated based on the percentage of fragments within the 300–4000 nucleotide range to account for RNA degradation. An nCounter® PanCancer Immune Profiling (IP) Panel and nCounter® Myeloid Innate Immunity (MII) Panel, each consisting of 730 genes and 40 housekeeping genes, were used for NanoString targeted gene expression analysis of the 88 whole-blood samples
Label n.a.
Label protocol n.a.
 
Hybridization protocol For each sample, a total of 200 ng RNA, in a maximum volume of 7 μL, was subjected to hybridization with the two panels for a duration of 17 h at 65 °C, following the protocol provided by the manufacturer (NanoString Technologies Inc., Seattle, WA, USA).
Scan protocol The nCounter® FLEX platform was utilized to wash away the unbound probes and to count the genes by scanning 490 fields of view (FOV).
Data processing Data analysis was performed using the advanced analysis module (version 2.0) of nSolver software (version 4.0, NanoString Technology).
 
Submission date Aug 30, 2023
Last update date Sep 01, 2023
Contact name Willem de Koning
E-mail(s) w.dekoning.1@erasmusmc.nl
Organization name Erasmus University Medical Center
Street address Doctor Molewaterplein 40
City Rotterdam
State/province Zuid-Holland
ZIP/Postal code 3015 GD
Country Netherlands
 
Platform ID GPL33719
Series (1)
GSE241957 Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries — Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients

Data table header descriptions
ID_REF
VALUE Log2 transformed normalized expression

Data table
ID_REF VALUE
A2M 3.608516417
ABCB1 7.63642239
ABCC8 3.018091103
ABCF1 8.691596789
ABL1 6.974838605
ACAD10 6.554143942
ACLY 10.24690989
ACOD1 2.281125509
ACOT1 2.696163008
ACOT11 0.696163008
ACOX1 10.62245896
ADA 7.948366431
ADAM19 9.062485276
ADAM8 9.451050465
ADAMTS1 5.451050477
ADAMTS12 1.696163008
ADAMTS14 0.696163008
ADAMTS17 5.944090498
ADAMTS2 2.281125509
ADAMTS3 3.696163008

Total number of rows: 1186

Table truncated, full table size 20 Kbytes.




Supplementary file Size Download File type/resource
GSM7746590_pdac_15_before_IP.RCC.gz 8.6 Kb (ftp)(http) RCC
GSM7746590_pdac_15_before_MII.RCC.gz 8.5 Kb (ftp)(http) RCC
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap